Private Capital Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1588456
NAPLES, FL
Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,475,997
+$12,270,281 QoQ
Shares Held
166,016
-17.6% QoQ
Ownership
0.833%
of shares outstanding
% of Portfolio
5.37%
of 13F equity value
Holder Rank
#32
of 413 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 29%
Shared 71%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Capital Management, LLC holds $52,903,422 across 3 Biotechnology names. LGND ranks #1 (99.2% of the industry book) .
All Filings in LGND
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,475,997 | 166,016 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $40,205,716 | 201,381 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,495,021 | 208,891 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,238,768 | 227,158 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,061,481 | 229,253 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,573,862 | 148,125 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,324,883 | 133,690 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $13,400,049 | 133,880 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,333,391 | 134,505 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||